HIGHLIGHTS
- who: Andrea Fagiolini from the Universitu00e0 Di Siena, VLe Mario Bracci, , Siena (SI), Italy have published the research: Treatment persistence in patients with schizophrenia treated with lurasidone in Italian clinical practice, in the Journal: (JOURNAL)
- what: This study evaluated treatment persistence to lurasidone (LUR) in patients with schizophrenia in a real-world Italian setting. In fact, while none of the clinical and demographic variables considered in the study had a statistically significant relationship with LUR treatment persistence, in the study conducted in London, patients who were not treatment-resistant had a substantially reduced risk of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.